Matches in DBpedia 2014 for { <http://dbpedia.org/resource/IMAB362> ?p ?o. }
Showing items 1 to 22 of
22
with 100 items per page.
- IMAB362 abstract "IMAB362 (Claudiximab) is a monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG.The drug is in phase II clinical trials as of January 2013.".
- IMAB362 atcPrefix "none".
- IMAB362 wikiPageID "41420361".
- IMAB362 wikiPageRevisionID "595473505".
- IMAB362 atcPrefix "none".
- IMAB362 legalStatus "Investigational".
- IMAB362 mabType "mab".
- IMAB362 synonyms "claudiximab".
- IMAB362 target "CLDN18.2".
- IMAB362 type "mab".
- IMAB362 verifiedfields "changed".
- IMAB362 verifiedrevid "457124199".
- IMAB362 subject Category:Monoclonal_antibodies.
- IMAB362 type Drug.
- IMAB362 type FunctionalSubstance.
- IMAB362 comment "IMAB362 (Claudiximab) is a monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG.The drug is in phase II clinical trials as of January 2013.".
- IMAB362 label "IMAB362".
- IMAB362 sameAs m.0zrpj5j.
- IMAB362 sameAs Q17107865.
- IMAB362 sameAs Q17107865.
- IMAB362 wasDerivedFrom IMAB362?oldid=595473505.
- IMAB362 isPrimaryTopicOf IMAB362.